B

Bionano Genomics
D

BNGO

3.37000
USD
-0.10
(-2.88%)
مغلق
حجم التداول
524
الربح لكل سهم
-8
العائد الربحي
-
P/E
-0
حجم السوق
11,336,680
أصول ذات صلة
C
CRSP
-1.350
(-2.04%)
64.760 USD
E
EDIT
-0.11000
(-3.38%)
3.14000 USD
F
FATE
-0.01000
(-0.80%)
1.23500 USD
M
MCRB
0.940
(7.00%)
14.370 USD
N
NTLA
0.830
(6.50%)
13.595 USD
P
PACB
0.00000
(0.00%)
1.53500 USD
PSTG
PSTG
0.660
(1.16%)
57.590 USD
R
RGEN
-0.200
(-0.16%)
121.670 USD
T
TDOC
0.01000
(0.12%)
8.21000 USD
V
VCEL
0.410
(1.03%)
40.160 USD
المزيد
الأخبار المقالات

العنوان: Bionano Genomics Inc

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, ofwhich the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.